Company Information
Member Since 14 Years
Nature of Business Retailer
GST No. 27AAHPM3187H1ZGAsk for more detail from the seller
Contact Supplier
DESCRIPTION
Cresp (Darbepoetin alfa) Injection is a prescription drug used to treat anemia due to chronic kidney disease or due to chemotherapy. Cresp 40mcg injection is an erythropoiesis-stimulating agent (ESA). It Stimulates bone marrow to produce more red blood cells.
Dosage :
Renal Anemia: Hemodialysis Patients:
The usual dose of Cresp in adult patients is 20 μg as Cresp (genetical recombination), to be administered as a single intravenous injection once weekly.
Peritoneal Dialysis Patients And Patients With Chronic Kidney Disease Not On Dialysis:
The usual dose of Cresp in adult patients is 30 μg as Cresp (genetical recombination), to be administered as a single injection once every two weeks subcutaneously or intravenously.
Treatment of Anemia in Cancer Patients Receiving Myelosuppressive Chemotherapy:
Initiate Cresp in patients on cancer chemotherapy only if the hemoglobin is less than 10 g/dL, and if there is a minimum of two additional months of planned chemotherapy.
SIDE EFFECTS
Common side effects are Increased blood pressure, Hypersensitivity.
Connect with us
For Buyer 
For Seller 
Help 
Kandivali East, Mumbai, Maharashtra 
Send Enquiry